Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,020 | 26 | 94.7% |
| Food and Beverage | $900.94 | 42 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $16,020 | 26 | $0 (2022) |
| Lundbeck LLC | $198.27 | 12 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $131.75 | 2 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $128.79 | 5 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $123.65 | 7 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $75.62 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $69.98 | 4 | $0 (2018) |
| Alkermes, Inc. | $61.97 | 3 | $0 (2018) |
| BeiGene USA, Inc. | $49.02 | 1 | $0 (2024) |
| Allergan Inc. | $47.79 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.02 | 1 | BeiGene USA, Inc. ($49.02) |
| 2022 | $2,910 | 6 | CSL Behring ($2,910) |
| 2021 | $7,980 | 15 | CSL Behring ($7,980) |
| 2020 | $5,130 | 5 | CSL Behring ($5,130) |
| 2019 | $86.53 | 3 | Neurocrine Biosciences, Inc. ($63.20) |
| 2018 | $559.13 | 26 | Teva Pharmaceuticals USA, Inc. ($131.75) |
| 2017 | $206.26 | 12 | Lundbeck LLC ($103.94) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $49.02 | General |
| Category: Oncology | ||||||
| 05/30/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $330.00 | General |
| 05/16/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 04/27/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 04/12/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| 01/18/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $360.00 | General |
| 01/05/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 12/30/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $120.00 | General |
| 10/21/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $270.00 | General |
| 09/07/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $360.00 | General |
| 08/16/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 08/02/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 07/13/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $390.00 | General |
| 06/08/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $390.00 | General |
| 05/07/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 04/26/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| 04/01/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| 03/17/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $360.00 | General |
| 02/15/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $180.00 | General |
| 02/02/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 01/20/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 01/11/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| 12/29/2020 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $480.00 | General |
| 12/10/2020 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $990.00 | General |
| 10/21/2020 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 40 | $5,976 | $2,385 |
| 2022 | 2 | 62 | 119 | $21,462 | $7,508 |
| 2021 | 3 | 88 | 156 | $24,975 | $8,371 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 40 | $5,976 | $2,385 | 39.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 102 | $15,282 | $5,313 | 34.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 15 | 17 | $6,180 | $2,195 | 35.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 93 | $13,950 | $5,063 | 36.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 14 | 14 | $5,635 | $1,927 | 34.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 29 | 49 | $5,390 | $1,382 | 25.6% |
About Dr. Rizwan Ali, MD
Dr. Rizwan Ali, MD is a Psychiatry healthcare provider based in Harrodsburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871662684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Ali, MD has received a total of $16,921 in payments from pharmaceutical and medical device companies, with $49.02 received in 2024. These payments were reported across 68 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($16,020).
As a Medicare-enrolled provider, Ali has provided services to 170 Medicare beneficiaries, totaling 315 services with total Medicare billing of $18,265. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Harrodsburg, KY
- Active Since 11/07/2006
- Last Updated 11/09/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1871662684
Products in Payments
- ABILIFY MAINTENA (Drug) $234.53
- AUSTEDO (Drug) $131.75
- INGREZZA (Drug) $128.79
- REXULTI (Drug) $87.39
- LATUDA (Drug) $75.62
- INVEGA SUSTENNA (Drug) $69.98
- Aristada 441 mg (Drug) $61.97
- BRUKINSA (Drug) $49.02
- VRAYLAR (Drug) $47.79
- SUBLOCADE (Drug) $14.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.